Dosidal · Switzerland
Daunoblastin, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:68340 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 68340 atc: L01DB02 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 2021-11-04 term: zugelassen valid_until: 9999-12-31 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: L01DB02 authorisation_number: 68340 form: PULPI holder: Pfizer AG holder_partner_nr: 1001107 it_number: 07.16.1. name: Daunoblastin, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53E778zmQNET1KQt9fWTbclpNFmcHoQ3KS0CdDOTBVDEZPULLtj3gCUNkwMhviiLbCoS-JESAy_HmWMer9y4JRHwVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/ch:authorisation:68340 · Same medicine in other markets · Dosidal